Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
No open-market purchases or sales by Nuvectis Pharma, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Nuvectis Pharma, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +2 vs. Q4 2024
- Shares held
- 2.05M
- +726.4K (+55.0%) vs. Q4 2024
- Total value
- $20.0M
- +$12.9M (+180.6%) vs. Q4 2024
- New holders
- 10
- 13 more added
- Sold out
- 8
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $189.0M |
| Q1 2026 | 62 | $34.9M |
| Q4 2025 | 48 | $32.0M |
| Q3 2025 | 53 | $22.2M |
| Q2 2025 | 47 | $24.2M |
| Q1 2025 | 33 | $20.0M |
| Q4 2024 | 31 | $7.15M |
| Q3 2024 | 31 | $6.60M |
| Q2 2024 | 41 | $7.63M |
| Q1 2024 | 40 | $12.8M |
| Q4 2023 | 36 | $12.6M |
| Q3 2023 | 33 | $16.5M |
| Q2 2023 | 37 | $20.0M |
| Q1 2023 | 13 | $6.34M |
| Q4 2022 | 11 | $7.38M |
| Q3 2022 | 12 | $10.0M |
| Q2 2022 | 11 | $7.20M |
| Q1 2022 | 8 | $4.65M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Nuvectis Pharma, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Steward Partners Investment Advisory, LLC | 100 | $977 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 102 | $997 | 0.00% | −13−11.3% | Reduced |
| JPMorgan Chase & Co | 179 | $1.75K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,025 | $10.0K | 0.00% | +1,025 | New |
| Barclays PLC | 1,159 | $11.3K | 0.00% | +15+1.3% | Added |
| Bank of America Corp | 1,656 | $16.2K | 0.00% | +41+2.5% | Added |
| Morgan Stanley | 6,977 | $68.2K | 0.00% | +4,658+200.9% | Added |
| Jain Global LLC | 10,154 | $99.2K | 0.00% | +10,154 | New |
| Citadel Advisors LLC | 10,344 | $101.1K | 0.00% | +10,344 | New |
| Blue Zone Wealth Advisors, LLC | 10,424 | $101.8K | 0.03% | +10,424 | New |
| Squarepoint Ops LLC | 11,012 | $107.6K | 0.00% | −8,059−42.3% | Reduced |
| Balyasny Asset Management LLC | 13,483 | $131.7K | 0.00% | +13,483 | New |
| Nations Financial Group Inc, | 13,500 | $131.9K | 0.01% | 00.0% | Unchanged |
| Baxter Bros Inc | 15,000 | $146.6K | 0.02% | 00.0% | Unchanged |
| Edmond de Rothschild Holding S.A. | 15,170 | $148.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 20,093 | $196.3K | 0.00% | +1,523+8.2% | Added |
| State Street Corp | 27,750 | $271.1K | 0.00% | +5,750+26.1% | Added |
| Omers Administration Corp | 32,882 | $321.3K | 0.00% | +32,882 | New |
| Gsa Capital Partners LLP | 34,751 | $340.0K | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 38,058 | $371.8K | 0.00% | +12,333+47.9% | Added |
| Marshall Wace, LLP | 38,874 | $379.8K | 0.00% | −85,697−68.8% | Reduced |
| Oppenheimer & Co Inc | 41,000 | $400.6K | 0.01% | +16,000+64.0% | Added |
| Jane Street Group, LLC | 42,299 | $413.3K | 0.00% | +42,299 | New |
| Austin Wealth Management, LLC | 40,250 | $441.1K | 0.09% | +40,250 | New |
| Goldman Sachs Group Inc | 45,608 | $445.6K | 0.00% | +45,608 | New |
| Forbes J M & Co LLP | 59,000 | $576.4K | 0.06% | 00.0% | Unchanged |
| BlackRock, Inc. | 68,484 | $669.1K | 0.00% | +6,142+9.9% | Added |
| UBS Group AG | 111,520 | $1.09M | 0.00% | +108,851+4,078.3% | Added |
| Millennium Management LLC | 121,101 | $1.18M | 0.00% | +91,403+307.8% | Added |
| Geode Capital Management, LLC | 135,333 | $1.32M | 0.00% | +56,090+70.8% | Added |
| Iridian Asset Management LLC | 253,972 | $2.48M | 0.78% | +253,972 | New |
| Baldwin Brothers Inc | 358,461 | $3.50M | 0.25% | +2,500+0.7% | Added |
| Vanguard Group Inc | 467,419 | $4.57M | 0.00% | +142,122+43.7% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −45,607−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −30,594−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −6,294−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −4,479−100.0% | Sold out |
| Hollencrest Capital Management | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −310−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |